Transdermal Drug Delivery Systems and Skin Sensitivity Reactions
- 1 November 2000
- journal article
- review article
- Published by Springer Nature in American Journal of Clinical Dermatology
- Vol. 1 (6) , 361-368
- https://doi.org/10.2165/00128071-200001060-00004
Abstract
Transdermal devices are now marketed for the delivery of systemic medication through the skin. Advantages associated with transdermal drug delivery include avoidance of first-pass metabolism and...Keywords
This publication has 50 references indexed in Scilit:
- Predictors and Timing of Adverse Experiences During Transdermal Nicotine TherapyDrug Safety, 1999
- Transdermal fentanyl versussustained-release oral morphine in cancer pain: Preference, efficacy, and quality of lifeJournal of Pain and Symptom Management, 1997
- Effect of coadministration of corticosteroids on the development of contact sensitizationJournal of the American Academy of Dermatology, 1996
- Adverse skin reactions to nicotine in a transdermal therapeutic systemContact Dermatitis, 1991
- The hazards of defibrillation through nitroglycerin patchesAnnals of Emergency Medicine, 1990
- Allergic contact dermatitis from transdermal nitroglycerinContact Dermatitis, 1989
- Contact dermatitis to transdermal estradiol systemJournal of the American Academy of Dermatology, 1989
- Transdermal antihypertensive therapy: Clinical and metabolic considerationsAmerican Heart Journal, 1986
- Clinical acceptability of transdermal clonidine: A large-scale evaluation by practitionersAmerican Heart Journal, 1986
- Delayed hypersensitivity to scopolamine delivered by a transdermal deviceJournal of the American Academy of Dermatology, 1985